DavidsonMR, GazdarAF, ClarkeBE. The pivotal role of pathology in the management of lung cancer. J Thorac Dis, 2013; 5(Suppl 5):S463–S478.
2.
MukhopadhyayS, KatzensteinA. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Path, 2011; 35(1):15–25.
VázquezS, LázaroM, FírvidaJL, SantoméL, AfonsoJ, AmenedoM, et al. Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile. Anticancer Drugs, 2014; 25(4):368–374.
5.
TravisW, BrambillaE, NoguchiM, NicholsonA, GeisingerK, YatabeY, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Onc, 2011; 6(2):244.
6.
TochigiN, DacicS, NikiforovaM, CieplyKM, YousemSA. Adenosquamous carcinoma of the lung: a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population. Am J Clin Pathol, 2011; 135(5):783–789.
7.
CookeDT, NguyenDV, YangY, ChenSL, YuC, CalhounRF. Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy. Ann Thorac Surg, 2010; 90(3):943–948.
8.
MordantP, GrandB, CazesA, FoucaultC, DujonA, Le Pimpec BarthesF, RiquetM. Adenosquamous carcinoma of the lung: surgical management, pathological characteristics, and prognostic implications. Ann Thorac Surg, 2013; 95(4):1189–1195.
9.
KazerooniEA, BhallaM, ShepardJA, McLoudTC. Adenosquamous carcinoma of the lung: radiologic appearance. Am J Roentgenol, 1994; 163(2):301–306.
